Previous 10 | Next 10 |
MONSEY, N.Y., Feb. 07, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether Catalent, Inc. (NYSE: CTLT) (“Catalent”) has violated federal securities laws based on a report by Bloomberg alleging that inspectors from the U.S. Food and Drug Administ...
2024-02-06 16:16:24 ET More on Catalent Catalent: Debt Remains An Overhang Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript Catalent, Inc. 2024 Q1 - Results - Earnings Call Presentation Lilly reportedly worried about impact of Catalent/Novo deal ...
2024-02-06 13:23:49 ET More on Catalent, Eli Lilly, etc. Eli Lilly and Company 2023 Q4 - Results - Earnings Call Presentation Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript ...
2024-02-06 07:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for CTLT on February 6, 2024 07:54AM ET. The previous analyst recommendation was Outperform. CTLT was trading at $59.82 at issue of the analyst recommendation. The overall analyst consensus :...
2024-02-06 01:10:00 ET Summary Some big tech results fizzled, but there were two standouts last week. Nine S&P 500® companies have outlier earnings dates this week - MCD, IEX, EW, MAA, MCK, HSY, COP, TROW, CTLT. 1,558 companies are expected to report during the second...
2024-02-05 18:25:27 ET Shares of Catalent (NYSE: CTLT) rose by 9.7% on Monday after the pharmaceutical contract manufacturing and drug delivery technology specialist agreed to be acquired by Novo Holdings, the parent company of Novo Nordisk (NYSE: NVO) . In a press relea...
2024-02-05 18:07:44 ET A major acquisition by its controlling shareholder pushed Novo Nordisk 's (NYSE: NVO) U.S.-listed shares 4% higher on Monday. As a result of the deal, Novo Nordisk will acquire from that shareholder (Novo Holdings) three fill-finish sites currently operated by...
2024-02-05 15:46:06 ET More on Catalent, Novo Nordisk, etc. Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript Biotech And Pharma Diversification Pays Off Novo Nordisk: Outlook For Weight Loss Drugs In 2024 Biggest stock movers today: Nvidia, Air Product...
2024-02-05 12:38:30 ET More on Eli Lilly Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Biotech And Pharma Diversification Pays Off Eli Lilly: The Cupboard Is Fully Stocked Eli Lilly sees highest intraday trade since November...
2024-02-05 10:51:44 ET More on Eli Lilly Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Biotech And Pharma Diversification Pays Off Eli Lilly: The Cupboard Is Fully Stocked U.S. govt. opens bids in Medicare drug price negotia...
News, Short Squeeze, Breakout and More Instantly...
Catalent Inc. Company Name:
CTLT Stock Symbol:
NYSE Market:
Catalent, Inc. (“Catalent,” NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, today announced that, at its Special Meeting of Stockholders (the “Special Meeting”) held earlier today, its stockholders voted to appr...
2024-05-20 04:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Q3'24 net revenue of $1.07 billion increased 4% as reported, or 3% in constant currency (1) , compared to Q3'23. Q3'24 net revenue, excluding COVID-related revenue of ~$120 million in Q3’23 and ~$60 million in Q3’24, increased 11% compared to Q3'23. Q3'24...